Nexstar Media Group, Inc. (NXST)
NASDAQ: NXST · Real-Time Price · USD
184.26
-2.85 (-1.52%)
At close: Aug 1, 2025, 4:00 PM
184.60
+0.34 (0.18%)
After-hours: Aug 1, 2025, 4:10 PM EDT
Regulus Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts that cover Regulus Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $206.43, which forecasts a 12.03% increase in the stock price over the next year. The lowest target is $200 and the highest is $220.
Price Target: $206.43 (+12.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Regulus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $200 | Buy | Maintains | $200 | +8.54% | Jul 30, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $200 | Buy | Maintains | $200 | +8.54% | May 13, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $215 → $220 | Strong Buy | Maintains | $215 → $220 | +19.40% | May 9, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $225 → $215 | Strong Buy | Maintains | $225 → $215 | +16.68% | May 6, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $216 → $200 | Buy | Maintains | $216 → $200 | +8.54% | May 1, 2025 |
Financial Forecast
Revenue This Year
5.03B
from 5.41B
Decreased by -6.95%
Revenue Next Year
5.54B
from 5.03B
Increased by 10.12%
EPS This Year
13.43
from 21.41
Decreased by -37.25%
EPS Next Year
26.79
from 13.43
Increased by 99.44%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.2B | 5.8B | 5.6B | ||
| Avg | 5.0B | 5.5B | 5.2B | ||
| Low | 4.8B | 5.2B | 4.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.9% | 15.6% | 0.4% | ||
| Avg | -7.0% | 10.1% | -6.3% | ||
| Low | -11.6% | 3.1% | -14.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.39 | 32.50 | 24.00 | ||
| Avg | 13.43 | 26.79 | 19.05 | ||
| Low | 8.60 | 18.86 | 12.85 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -28.1% | 141.9% | -10.4% | ||
| Avg | -37.3% | 99.4% | -28.9% | ||
| Low | -59.8% | 40.4% | -52.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.